Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future Perspectives.

Cancers (Basel) · 2022 · PMC9658535 · PMID 36358801

Europe PMC DOI

hedged sentence

0.9100

closest p · 18.2× alpha

0.9100

boldest claim

The sentences

did not reach statistical significancep = 0.91not close (p > 0.1)

In a retrospective study of 1028 OPSCC patients (59% were HPV+) by Hall et al., a 13% benefit in OS for CRT was observed compared to RT only for the HPV+ cohort, but this difference did not reach statistical significance (HR = 0.948, 95% CI 0.642–1.400, p = 0.91) [ 40 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.